The PIERS experience: research or quality improvement?

Affiliations

Free article

Tabassum Firoz et al. J Obstet Gynaecol Can. 2012 Apr.

Free article

. 2012 Apr;34(4):379-81.

doi: 10.1016/s1701-2163(16)35221-5.

No abstract available

Similar articles

Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study.
Yen TW, Payne B, Qu Z, Hutcheon JA, Lee T, Magee LA, Walters BN, von Dadelszen P; PIERS (Pre-eclampsia Integrated Estimate of RiSk) Study Group. Yen TW, et al. J Obstet Gynaecol Can. 2011 Aug;33(8):803-809. doi: 10.1016/S1701-2163(16)34983-0. J Obstet Gynaecol Can. 2011. PMID: 21846435
Evaluation of a definition of pre-eclampsia.
North RA, Taylor RS, Schellenberg JC. North RA, et al. Br J Obstet Gynaecol. 1999 Aug;106(8):767-73. doi: 10.1111/j.1471-0528.1999.tb08396.x. Br J Obstet Gynaecol. 1999. PMID: 10453825
Maternal mortality and safe motherhood.
Choolani M, Ratnam SS. Choolani M, et al. Southeast Asian J Trop Med Public Health. 1997;28 Suppl 2:148-50. Southeast Asian J Trop Med Public Health. 1997. PMID: 9561653 No abstract available.
Serum uric acid and pre-eclampsia: an update.
Bellomo G. Bellomo G. Expert Rev Cardiovasc Ther. 2012 Jun;10(6):701-5. doi: 10.1586/erc.12.51. Expert Rev Cardiovasc Ther. 2012. PMID: 22894626 Review.
Predicting adverse outcomes in women with severe pre-eclampsia.
von Dadelszen P, Menzies JM, Payne B, Magee LA; PIERS (Pre-eclampsia Integrated Estimate of RiSk) Study Group. von Dadelszen P, et al. Semin Perinatol. 2009 Jun;33(3):152-7. doi: 10.1053/j.semperi.2009.02.009. Semin Perinatol. 2009. PMID: 19464505 Review.